TLDR
- UnitedHealth delivered first quarter adjusted EPS of $7.23, surpassing analyst expectations of $6.58, while revenue reached $111.7 billion versus the anticipated $109.4 billion.
- Shares climbed 5.7% to $342 during Tuesday’s premarket session.
- Annual adjusted EPS forecast elevated to above $18.25, increased from the January projection of $17.75.
- Medical care ratio enhanced to 83.9% in Q1 2026, compared to 84.8% in the prior-year quarter.
- The healthcare giant is committing a minimum of $1.5 billion to AI initiatives to counteract a $6 billion Medicare reimbursement challenge.
UnitedHealth Group delivered robust first-quarter performance, exceeding Wall Street projections for both profitability and top-line growth while increasing its annual forecast. These results emerge as the healthcare behemoth advances its transformation initiatives under CEO Stephen Hemsley, who resumed leadership last May.
$UNH Q1 EARNINGS
• Revenue $111.7B vs Est. $109.2B
• EPS $7.23 vs Est. $6.57
• Medical Care Ratio: 83.9%FY26 Guidance
• EPS $18.25 vs Est. $17.75Authorized a $2B stock buyback to be completed by the end of Q2 2026. pic.twitter.com/aCgKHcjMbq
— Shay Boloor (@StockSavvyShay) April 21, 2026
First quarter adjusted profit reached $7.23 per share, substantially exceeding the consensus projection of $6.58. Top-line performance totaled $111.7 billion, surpassing analyst forecasts of $109.4 billion. The company reported net income of $6.28 billion, translating to $6.90 per share.
Shares advanced 5.7% to $342 during Tuesday’s premarket session.
UnitedHealth Group Incorporated, UNH
Annual adjusted EPS projections were elevated to exceed $18.25, representing an increase from the $17.75 outlook provided in January. CFO Wayne DeVeydt informed Barron’s that management would probably postpone additional revisions until after the second quarter. “We’d like to just see a few more months get under our belt,” he noted.
UnitedHealthcare segment revenues expanded to $86.3 billion during the quarter, compared to $84.6 billion in the first quarter of 2025. Operating margin reached 6.6%, improving from 6.2% in the comparable period.
Medical Costs Show Improvement
Among the most encouraging indicators in the quarterly report was the medical care ratio — representing the proportion of premium income allocated to medical expenses. This metric declined to 83.9% in Q1 2026 from 84.8% in Q1 2025. This represents a substantial improvement following the ratio reaching 91.5% in Q4 2025.
Management credited the enhancement to expense controls and positive reserve adjustments. However, increased utilization patterns and higher unit costs partially diminished these benefits.
UnitedHealth has been withdrawing from less profitable segments, including individual ACA marketplace plans and select Medicare Advantage regions. This strategic repositioning led to membership declining from 49.8 million at the close of 2025 to 49.1 million in Q1 2026. Medicare Advantage participants decreased by 965,000 during the quarter.
Optum and AI Investment
Optum Health, which faced challenges throughout most of 2025, generated $1.3 billion in adjusted operating earnings during Q1. DeVeydt characterized it as a “very good start” relative to full-year targets exceeding $1.6 billion. “We view this as a multiyear journey,” he commented.
UnitedHealth is deploying a minimum of $1.5 billion toward artificial intelligence capabilities this year. Company executives indicate these technology investments are proving instrumental in addressing a $6 billion obstacle stemming from previous Medicare payment modifications. DeVeydt emphasized that the return period on AI projects is “very short.”
Earlier in April, the Medicare administration validated an average 2.48% payment increase for insurance providers in the upcoming year. UNH shares had already appreciated 9% following that announcement. DeVeydt conceded the adjustment “didn’t fully address” existing medical cost trajectories, indicating benefit reductions remain necessary in 2026.
Morgan Stanley elevated UNH to a “top pick” designation on April 16, pointing to expectations for a “string of clean quarters” subsequent to the more advantageous Medicare rate disclosure.
UnitedHealthcare’s employer-based self-funded operations helped mitigate some membership declines, while the company’s OptumRx pharmacy benefit division also bolstered overall revenue expansion.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
